Name and identity
Use “CannaWize” as one word with a capital C and W. Do not alter the name, leaf icon, wordmark proportions, or colors in a way that creates confusion about source or ownership.
Editorial licensing
A license should identify the exact work, permitted channels, territory, duration, modification rights, attribution, payment, update obligations, and archival treatment. Ownership is not transferred unless a signed agreement explicitly says so.
Attribution
Licensed work should credit CannaWize and the named author, link to the canonical source when digital, preserve material disclosures, and identify substantive edits made by the licensee.
Research and data
Source dates, methodology, definitions, exclusions, and limitations must travel with licensed research or structured data. A partner may not remove uncertainty language or present a CannaWize synthesis as original clinical research.
Corrections and updates
Licensees must provide a practical way to correct material errors. When CannaWize issues a material correction, an active licensee should update or annotate the licensed version within the time stated in the agreement.
Prohibited implications
- CannaWize certified, approved, prescribed, tested, or medically endorsed a product when it did not.
- A regulator, clinician, university, or professional organization endorsed the work without written authorization.
- Licensed editorial coverage is independent news when it was commissioned commercial work.
- A partner may suppress corrections, safety information, or material limitations.
- The CannaWize name may be used on unlawful, youth-oriented, deceptive, or unsubstantiated health marketing.
Trademark and legal review
These standards describe intended brand use. They do not claim that every category has a registered trademark. Federal and state protection should be evaluated with qualified counsel for the specific goods and services involved.